|
1
|
Id-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic target.
|
Cancer Res
|
2012
|
1.14
|
|
2
|
Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival.
|
Mol Cancer Ther
|
2010
|
1.00
|
|
3
|
Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid.
|
Amyotroph Lateral Scler Other Motor Neuron Disord
|
2004
|
0.90
|
|
4
|
Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A) receptors without diminishing nervous system function or chemotherapy efficacy.
|
Br J Pharmacol
|
2014
|
0.88
|
|
5
|
Targeting Id1 reduces proliferation and invasion in aggressive human salivary gland cancer cells.
|
BMC Cancer
|
2013
|
0.85
|
|
6
|
Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer.
|
Br J Pharmacol
|
2014
|
0.82
|
|
7
|
Novel therapeutic strategies for malignant salivary gland tumors: lessons learned from breast cancer.
|
Int J Otolaryngol
|
2011
|
0.80
|